Literature DB >> 2057539

Effect of clomipramine on sleep and EEG power spectra in the diurnal rodent Eutamias sibiricus.

D J Dijk1, A Strijkstra, S Daan, D G Beersma, R H Van den Hoofdakker.   

Abstract

Sleep was recorded in the diurnal rodent Eutamias sibiricus, chronically implanted with EEG and EMG electrodes. The tricyclic antidepressant drug clomipramine suppressed the duration of REM sleep and EEG power density in the frequencies between 1.5 and 13.5 Hz in nonREM sleep. During the administration of clomipramine, 24 h of sleep deprivation by forced locomotion significantly reduced the duration of waking and increased the duration of nonREM sleep. During the first 2 h of recovery sleep, EEG power density of the frequencies between 2.5 and 6 Hz was enhanced. These effects of sleep deprivation were to a large extent similar to those of sleep deprivation under drug free conditions. It is concluded that clomipramine affects the EEG in nonREM sleep but does not interfere substantially with nonREM sleep regulatory processes, which are activated by sleep deprivation.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2057539     DOI: 10.1007/bf02244292

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  12 in total

1.  REM sleep deprivation during 5 hours leads to an immediate REM sleep rebound and to suppression of non-REM sleep intensity.

Authors:  D G Beersma; D J Dijk; C G Blok; I Everhardus
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1990-08

2.  Changes during weeks in effects of tricyclic drugs on the human sleeping brain.

Authors:  D L Dunleavy; V Brezinova; I Oswald; A W Maclean; M Tinker
Journal:  Br J Psychiatry       Date:  1972-06       Impact factor: 9.319

3.  Sleep, sleep deprivation and depression. A hypothesis derived from a model of sleep regulation.

Authors:  A A Borbély; A Wirz-Justice
Journal:  Hum Neurobiol       Date:  1982

4.  Sleep deprivation: effect on sleep stages and EEG power density in man.

Authors:  A A Borbély; F Baumann; D Brandeis; I Strauch; D Lehmann
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1981-05

5.  Improvement of depression by REM sleep deprivation. New findings and a theory.

Authors:  G W Vogel; F Vogel; R S McAbee; A J Thurmond
Journal:  Arch Gen Psychiatry       Date:  1980-03

6.  Sleep and EEG spectra in the Syrian hamster (Mesocricetus auratus) under baseline conditions and following sleep deprivation.

Authors:  I Tobler; K Jaggi
Journal:  J Comp Physiol A       Date:  1987-08       Impact factor: 1.836

7.  Platform sleep deprivation affects deep slow wave sleep in addition to REM sleep.

Authors:  S Grahnstedt; R Ursin
Journal:  Behav Brain Res       Date:  1985-12       Impact factor: 3.332

8.  Effect of sleep deprivation on sleep and EEG power spectra in the rat.

Authors:  A A Borbély; I Tobler; M Hanagasioglu
Journal:  Behav Brain Res       Date:  1984-12       Impact factor: 3.332

9.  Sleep EEG spectral analysis in a diurnal rodent: Eutamias sibiricus.

Authors:  D J Dijk; S Daan
Journal:  J Comp Physiol A       Date:  1989       Impact factor: 1.836

10.  Effects on sleep: a double-blind study comparing trimipramine to imipramine in depressed insomniac patients.

Authors:  J C Ware; F W Brown; P J Moorad; J T Pittard; B Cobert
Journal:  Sleep       Date:  1989-12       Impact factor: 5.849

View more
  3 in total

1.  Sleep-related epilepsy in a Long-Evans hooded rat model of depression.

Authors:  Angela L McDowell; Kingman P Strohl; Pingfu Feng
Journal:  Sleep Breath       Date:  2011-12-29       Impact factor: 2.816

2.  Acute administration of the novel serotonin and noradrenaline reuptake inhibitor, S33005, markedly modifies sleep-wake cycle architecture in the rat.

Authors:  Raymond Cespuglio; Colette Rousset; Gabriel Debilly; Catherine Rochat; Mark J Millan
Journal:  Psychopharmacology (Berl)       Date:  2005-09-29       Impact factor: 4.530

3.  Effects of trazodone on EEG sleep and clinical state in major depression.

Authors:  A L van Bemmel; R G Havermans; R van Diest
Journal:  Psychopharmacology (Berl)       Date:  1992       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.